-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HGSzXataoGlCn4SNaW1uP2smdcdV5tmZ4EPErvaQlFtdy6NoI0Zatji80qdMa+B5 P/ewuD5E610OkAdXrTjeIw== 0000875320-08-000023.txt : 20080515 0000875320-08-000023.hdr.sgml : 20080515 20080515151054 ACCESSION NUMBER: 0000875320-08-000023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080513 FILED AS OF DATE: 20080515 DATE AS OF CHANGE: 20080515 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 08836892 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174446100 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2008-05-13 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256126 MUELLER PETER C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 0 1 0 0 EVP Drug Innov.& Realiz, CSO Common Stock 2008-05-13 4 S 0 100 27.00 D 87831 D Common Stock 2008-05-13 4 S 0 300 27.01 D 87531 D Common Stock 2008-05-13 4 S 0 34 27.03 D 87497 D Common Stock 2008-05-13 4 S 0 105 27.04 D 87392 D Common Stock 2008-05-13 4 S 0 102 27.05 D 87290 D Common Stock 2008-05-13 4 S 0 100 27.09 D 87190 D Common Stock 2008-05-13 4 S 0 200 27.11 D 86990 D Common Stock 2008-05-13 4 S 0 100 27.15 D 86890 D Common Stock 2008-05-13 4 S 0 100 27.16 D 86790 D Common Stock 2008-05-13 4 S 0 200 27.19 D 86590 D Common Stock 2008-05-13 4 S 0 200 27.37 D 86390 D Common Stock 3460 I 401(k) Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Valerie L. Andrews, Attorney-In-Fact 2008-05-15 -----END PRIVACY-ENHANCED MESSAGE-----